WT1 and non-small cell lung carcinoma: As proven above, WT1 exerted oncogenic activities by promoting NSCLC cell proliferation, survival and invasion, thus we suspected that its inhibitor, miR-498-5p, might possess the opposite tumour suppressive roles.